The rollout of paediatric dolutegravir and virological outcomes among children living with HIV in Mozambique
Background: In 2022, Mozambique introduced Dolutegravir 10mg (pDTG), as part of paediatric antiretroviral therapy for children weighing 20 kg. Understanding real-world challenges during national rollout can strengthen health systems in resource-limited settings. Objectives: We described the transi...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
AOSIS
2024-07-01
|
| Ráidu: | Southern African Journal of HIV Medicine |
| Fáttát: | |
| Liŋkkat: | https://sajhivmed.org.za/index.php/hivmed/article/view/1578 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|